The structure of the Montgomery-Asberg depression rating scale over the course of treatment for depression

被引:83
作者
Quilty, Lena C. [1 ,2 ]
Robinson, Jennifer J. [1 ,2 ]
Rolland, Jean-Pierre [3 ]
De Fruyt, Filip [4 ]
Rouillon, Frederic [5 ]
Bagby, R. Michael [1 ,2 ]
机构
[1] Ctr Addict & Mental Hlth, Toronto, ON M5T 1R8, Canada
[2] Univ Toronto, Toronto, ON, Canada
[3] Univ Paris Ouest Nanterre La Def, Paris, France
[4] Univ Ghent, B-9000 Ghent, Belgium
[5] Univ Paris 05, INSERM, U669, CMME Hop St Anne, F-75270 Paris 06, France
关键词
major depression; assessment; confirmatory factor analysis; gender invariance; MEASUREMENT INVARIANCE; FACTORIAL INVARIANCE; MAJOR DEPRESSION; MADRS; HAMILTON; SCHIZOPHRENIA; DISORDERS; ANXIETY; GENDER; MODEL;
D O I
10.1002/mpr.1388
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The Montgomery-angstrom sberg Depression Rating Scale (MADRS) is a widely used clinician-rated measure of depressive severity. Empirical support for the factor structure of the MADRS is mixed; further, the comparison of MADRS scores within and between patients requires the demonstration of consistent instrument properties. The objective of the current investigation was to evaluate MADRS factor structure as well as MADRS factorial invariance across time and gender. The MADRS was administered to 821 depressed outpatients participating in a large-scale effectiveness study of combined pharmacotherapy and psychotherapy for depression. Treatment outcome did not differ across treatment groups. Factor structure and invariance was evaluated via confirmatory factor analysis. A four-factor model consisting of Sadness, Negative Thoughts, Detachment and Neurovegetative symptoms demonstrated a good fit to the data. This four-factor structure was invariant across time and gender. A hierarchical model, in which these four factors served as indicators of a general depression factor, was also supported. A limitation of the current study is the lack of comprehensive characterization of patient clinical features; results need to be replicated in more severely depressed or treatment refractory patients. Overall, evidence supported the use of the MADRS total score as well as subscales focused on affective, cognitive, social and somatic aspects of depression in male and female outpatients. Copyright (c) 2013 John Wiley & Sons, Ltd.
引用
收藏
页码:175 / 184
页数:10
相关论文
共 50 条
[31]   An exploratory graphical analysis of the Montgomery-Asberg Depression Rating Scale pre- and post-treatment using pooled antidepressant trial secondary data [J].
Byrne, David ;
Ghoshal, Arunangshu ;
Boland, Fiona ;
Brannick, Susan ;
Carney, Robert M. ;
Cuijpers, Pim ;
Dima, Alexandra L. ;
Freedland, Kenneth E. ;
Guerin, Suzanne ;
Hevey, David ;
Kathuria, Bishember ;
Mcdarby, Vincent ;
Wallace, Emma ;
Doyle, Frank .
JOURNAL OF AFFECTIVE DISORDERS, 2025, 368 :584-590
[32]   Profile of Depressive symptoms in Late life based on Montgomery Asberg Depression Rating Scale [J].
Nakulan, Anisha ;
Sebind, K. ;
Sumesh, T. P. ;
Shaji, K. S. .
INDIAN JOURNAL OF PSYCHIATRY, 2015, 57 (05) :S57-S57
[33]   The inter-rater reliability of the Japanese version of the Montgomery-Asberg depression rating scale (MADRS) using a structured interview guide for MADRS (SIGMA [J].
Takahashi, N ;
Tomita, K ;
Higuchi, T ;
Inada, T .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2004, 19 (03) :187-192
[34]   Montgomery-Asberg Depression Rating Scale (MADRS) in Healthy Study Subjects, in Patients with Breast Disease and Breast Cancer: A Prospective Case-Control Study [J].
Eskelinen, Matti ;
Ollonen, Paula .
ANTICANCER RESEARCH, 2011, 31 (03) :1065-1069
[35]   Evaluation of depressive symptoms in patients with coronary artery disease using the Montgomery Asberg Depression Rating Scale [J].
Bunevicius, Adomas ;
Staniute, Margarita ;
Brozaitiene, Julija ;
Pommer, Antoinette M. ;
Pop, Victor J. M. ;
Montgomery, Stuart A. ;
Bunevicius, Robertas .
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2012, 27 (05) :249-255
[36]   Validation of the Hamilton Depression rating scale and Montgommery and Asberg Rating Scales in terms of AGECAT depression cases [J].
Mottram, P ;
Wilson, K ;
Copeland, J .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2000, 15 (12) :1113-1119
[37]   Agreement Between Hopelessness/Helplessness and Montgomery-Asberg Depression Rating Scale in Healthy Individuals and in Patients with Benign Breast Disease and Breast Cancer: A Prospective Case-Control Study in Finland [J].
Eskelinen, Matti ;
Korhonen, Riika ;
Selander, Tuomas ;
Ollonen, Paula .
ANTICANCER RESEARCH, 2015, 35 (04) :2215-2221
[38]   The Montgomery Asberg and the Hamilton ratings of depression: A comparison of measures [J].
Carmody, Thomas J. ;
Rush, A. John ;
Bernstein, Ira ;
Warden, Diane ;
Brannan, Stephen ;
Burnham, Daniel ;
Woo, Ada ;
Trivedi, Madhukar H. .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 (08) :601-611
[39]   Montgomery-Åsberg Depression Rating Scale factors in treatment-resistant depression at onset of treatment: Derivation, replication, and change over time during treatment with esketamine [J].
Borentain, Stephane ;
Gogate, Jagadish ;
Williamson, David ;
Carmody, Thomas ;
Trivedi, Madhukar ;
Jamieson, Carol ;
Cabrera, Patricia ;
Popova, Vanina ;
Wajs, Ewa ;
DiBernardo, Allitia ;
Daly, Ella J. .
INTERNATIONAL JOURNAL OF METHODS IN PSYCHIATRIC RESEARCH, 2022, 31 (04)
[40]   Relationship between Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) total scores in older adults with major depressive disorder: An analysis of the OPTIMUM clinical trial [J].
Kim, Helena K. ;
Lenze, Eric J. ;
Ainsworth, Nicholas J. ;
Blumberger, Daniel M. ;
Brownd, Patrick J. ;
Flint, Alastair J. ;
Karpf, Jordan F. ;
Lavretskyg, Helen ;
Lenard, Emily ;
Miller, J. Philip ;
Reynolds, Charles F. ;
Roosed, Steven P. ;
Mulsanta, Benoit H. .
JOURNAL OF AFFECTIVE DISORDERS, 2024, 361 :651-658